Filing Details
- Accession Number:
- 0001225208-21-014220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-30 16:30:36
- Reporting Period:
- 2021-11-26
- Accepted Time:
- 2021-11-30 16:30:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1488270 | M Douglas Lankler | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-26 | 124 | $54.32 | 106,193 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 909 | $54.45 | 105,284 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 1,133 | $54.26 | 104,151 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 1,497 | $54.47 | 102,654 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 1,677 | $54.46 | 100,977 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 2,736 | $54.39 | 98,241 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 4,200 | $54.50 | 94,041 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 4,500 | $54.55 | 89,541 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 5,203 | $54.17 | 84,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 5,765 | $54.40 | 78,573 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 5,856 | $54.31 | 72,717 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-26 | 6,400 | $54.30 | 66,317 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,668 | Indirect | By Rule 16b-3 Plan |
Billionaire Hedge Funds
